Browse by Person

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 7.


South, Emily, Cox, Edward Miles, Meader, Nicholas et al. (2 more authors) (2019) Strimvelis for treating severe combined immunodeficiency caused by adenosine deaminase deficiency : an evidence review group perspective of a NICE Highly Specialised Technology evaluation. PharmacoEconomics - Open. pp. 151-161.

Wade, Rosalind Fay, Jones-Diette, Julie Susan, Wright, Kath et al. (2 more authors) (2018) Hyperhidrosis Quality of Life Measures : Review and Patient Perspective. Journal of Dermatological Treatment. ISSN 0954-6634

Morgan, Philip James, Woolacott, Nerys Frances, Biswas, Mousumi et al. (3 more authors) (2017) Crizotinib for Untreated Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer : An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics. pp. 1-11. ISSN 1179-2027

Wade, Rosalind Fay, Hodgson, Robert, Biswas, Mousumi et al. (2 more authors) (2017) A Review of Ruxolitinib for the Treatment of Myelofibrosis : A Critique of the Evidence. PharmacoEconomics. pp. 203-213. ISSN 1179-2027

Wade, Rosalind Fay and Woolacott, Nerys Frances (2017) Systematic review of patient preference and adherence to the correct use of graduated compression stockings to prevent deep vein thrombosis in surgical patients. Journal of Advanced Nursing. pp. 336-348. ISSN 0309-2402

Corbett, Mark Stephen, Woolacott, Nerys Frances, Webster, Andrew Joseph et al. (1 more author) (2017) Innovative regenerative medicines in the EU : a better future in evidence? BMC Medicine. ISSN 1741-7015

Sideris, Eleftherios, Corbett, Mark Stephen, Palmer, Stephen John et al. (2 more authors) (2016) The Clinical and Cost Effectiveness of Apremilast for Treating Active Psoriatic Arthritis : A Critique of the Evidence. Pharmacoeconomics.. 1101–1110.

This list was generated on Mon Oct 14 10:28:52 2019 BST.